IPSC

Conviction 47HealthcareScan · Mon, Aug 10, 2026

IPSC$1.98-1.00%

ResistanceSupportVol 14Insider sell

Vol MA14 820.44K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Century Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.centurytx.com ↗

Price1.98

Change-1.00%

Gap+0.50%

Rel volume3.67×

Avg volume874.54K

Avg $ vol1.82M

SMA 202.09

SMA 502.21

SMA 2001.81

Price vs 50-10.33%

Price vs 200+9.63%

MA stackmixed

50/200 cross—

Supertrenddown · 2.34

RSI (14)42

MACD hist-0.01

MACD cross—

Stoch %K / %D25 / 20

ADX (14)17

+DI / −DI13 / 21

RSI divergence—

MACD divergence—

ATR %+6.58%

ADR %5.74%

52w high2.94

52w low0.4645

From 52w high-32.65%

Above 52w low+326.26%

New 52w highNo

SqueezeOff

Bollinger width19.96%

%B0.23

Donchian pos20.00%

Donchian high2.36

Donchian low1.89

AVWAP (52w high)2.30

vs AVWAP high-14.03%

AVWAP (52w low)1.94

vs AVWAP low+2.04%

OBV trendDown

Chaikin MF (20)-0.16

Today vs 20d3.67×

Avg vol (14d)820.44K

Avg vol (20d)874.54K

Avg $ vol (20d)1.82M

Market cap357.1M

RS 3m (vs SPY)-19.12%

RS 6m (vs SPY)+5.65%

RS line new highNo

Trend template4/8

Technical rank42.5

1 week+0.00%

1 month-12.00%

3 months-13.54%

6 months+16.47%

1 year+274.15%

YTD+99.01%

P/E-37.28

P/B1.35

P/S3.27

P/FCF-3.41

EPS-0.1400

Div yield—

ROE-3.62%

ROA-2.93%

Debt/Eq0.01

Current10.25

EV/EBITDA—

Gross margin—

Net margin-8.78%

Rev growth1556.76%

EPS growth92.43%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value309.79M

Revenue109.16M

Net income-21.64M

Gross profit—

Free cash flow-104.72M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out180.35M

Employees78

ListedFri, Jun 18, 2021

Free float72.21M

Float %40.2%

Short interest28.38M

Days to cover22.0d

Short volume71.7%

Squeeze score100 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction47 / 100

Pattern quality—

Tech rank42.5 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.53

Support1.92

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IPSC

All disclosures →

No recent disclosed trades by Congress in IPSC. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IPSC · 1 buy · 6 sells

Insider	Side	Shares	Value	Traded	Filed
Carr Douglas SVP Finance & Operations · Common Stock · 2026-08-03	Sell	275	$544	2026-08-03	2026-08-05
Carr Douglas SVP Finance & Operations · Common Stock · 2026-06-08	Sell	249	$526	2026-06-08	2026-06-09
Russotti Gregory See Remarks · Common Stock · 2026-06-08	Other	—	—	2026-06-08	2026-06-09
Russotti Gregory See Remarks · Common Stock · 2026-06-08	Sell	524	$1K	2026-06-08	2026-06-09
Pfeiffenberger Brent President and CEO · Common Stock · 2026-06-05	Tax	463	$986	2026-06-05	2026-06-09
Pfeiffenberger Brent President and CEO · Common Stock · 2026-05-15	Tax	31.17K	$73K	2026-05-15	2026-05-19
Carr Douglas SVP Finance & Operations · Common Stock · 2026-05-04	Sell	264	$618	2026-05-04	2026-05-06
Murphy Martin Patrick Director · Stock Option (right to buy) · 2025-12-09	Grant	88K	$0	2025-12-09	2026-04-10

SEC filings

EDGAR filings in IPSC · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.